Sign in
8-K

Current Report

HAEMONETICS CORP Filed Acc 0000313143-16-000123

Exit or restructuring costs · Executive or director change

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading may920168-k.htm…